studi
describ
novel
block
microspherebas
immunoassay
highli
sensit
specif
detect
antibodi
bovin
viral
diarrhoea
viru
bvdv
intraand
interassay
variabl
less
respect
variabl
bead
conjug
less
diagnost
perform
assay
evalu
test
total
serum
sampl
base
negativeposit
cutoff
valu
assay
sensit
specif
rel
elisa
new
microspher
immunoassay
provid
altern
convent
elisa
system
use
highthroughput
screen
bvd
control
programm
genu
pestiviru
famili
flavivirida
consist
four
approv
speci
bovin
viral
diarrhoea
viru
bovin
viral
diarrhoea
viru
classic
swine
fever
viru
csfv
border
diseas
viru
bdv
tent
speci
pestiviru
giraff
thiel
et
al
bvdv
infect
usual
mild
inappar
clinic
baker
sever
hemorrhag
syndrom
also
observ
acut
infect
perdrizet
et
al
corapi
et
al
ridpath
et
al
diaplacent
infect
lead
birth
persist
infect
anim
serv
reservoir
spread
viru
sandvik
bvd
consid
one
major
diseas
worldwid
econom
impact
cattl
industri
exampl
cost
bvdv
infect
estim
per
cow
dairi
herd
new
zealand
reichel
et
al
may
exceed
per
cow
infect
high
virul
strain
coinfect
pathogen
pritchard
et
al
carman
et
al
houe
sweden
one
first
countri
implement
nation
bvdverad
programm
sinc
lindberg
aleniu
countri
almost
free
bvdv
et
al
lindberg
et
al
serolog
test
includ
viru
neutral
elisa
use
wide
detect
bvdv
antibodi
recent
advanc
microspherebas
flow
cytometr
technolog
provid
possibl
develop
multiplex
diagnost
assay
singl
platform
assay
design
sensit
convent
immunoassay
due
use
small
bead
lead
better
reaction
kinet
approach
liquidphas
condit
chromophor
phycoerythrin
except
bright
report
dye
krishhan
et
al
microspher
use
luminex
xmap
technolog
luminex
corp
austin
tx
code
uniqu
combin
fluoresc
dye
immobil
captur
molecul
eg
antibodi
immunoassay
develop
similar
way
elisa
signal
detect
process
luminex
analyz
use
xmap
technolog
rang
diagnost
assay
develop
recent
year
improv
serolog
detect
virus
eg
respiratori
syncyti
viru
caus
maladi
jone
et
al
human
immunodefici
viru
faucher
et
al
human
papillomavirus
dia
et
al
equin
arter
viru
go
et
al
avian
influenza
viru
watson
et
al
object
studi
develop
block
microspherebas
immunoassay
bmia
detect
antibodi
bvdv
compar
perform
assay
commerci
elisa
kit
total
serum
sampl
evalu
studi
includ
clinic
sampl
sweden
present
sampl
includ
sera
svanova
biotech
ab
uppsala
sweden
bovin
turbin
tb
cell
maintain
fdmem
foetal
calf
serum
lglutamin
antibiot
cell
confluenc
infect
oregon
kindli
provid
prof
martin
beer
institut
diagnost
virolog
friedrichloefflerinstitut
fli
greifswaldinsel
riem
germani
h
postinfect
cultur
frozen
c
thaw
nonidet
ad
cell
lysat
incub
c
h
follow
centrifug
g
min
supernat
taken
viral
antigen
microplex
microspher
purchas
luminex
corp
austin
tx
coupl
reaction
perform
accord
manufactur
instruct
briefli
million
microspher
resuspend
l
activ
buffer
mm
monobas
sodium
phosphat
ph
microspher
activ
l
mgml
nhydroxysulfosuccin
sulfonh
pierc
rockford
il
follow
l
mgml
carbodiimid
edc
pierc
rockford
il
incub
room
temperatur
endoverend
rotat
min
microspher
wash
twice
l
mm
morpholineethanesulfon
acid
me
ph
resuspend
l
mm
me
two
mab
describ
previous
block
elisa
paton
et
al
kramp
et
al
ad
activ
microspher
respect
incub
microspher
wash
twice
pbstbn
pb
bsa
azid
resuspend
l
buffer
pbstbn
store
c
dark
coupl
reaction
confirm
measur
fluoresc
intens
luminex
analyz
incub
microspher
twofold
serial
dilut
gml
rphycoerythrin
conjug
antimous
igg
sigmaaldrich
co
st
loui
mo
min
biotin
label
reaction
perform
accord
manufactur
instruct
pierc
rockford
il
briefli
g
incub
ice
l
sulfonhslcbiotin
h
remov
excess
biotin
use
desalt
column
biotinyl
mab
store
c
use
microspher
microspheresl
viral
antigen
dilut
serum
sampl
mix
equal
volum
l
incub
min
plate
shaker
dark
addit
l
biotinyl
mab
incub
anoth
min
l
gml
rphycoerythrinconjug
streptavidin
prozym
san
leandro
ca
ad
follow
incub
min
sampl
test
duplic
indic
specif
fluoresc
intens
reaction
measur
luminex
analyz
median
fluoresc
intens
mfi
calcul
base
measur
bead
per
sampl
result
express
inhibit
percentag
calcul
follow
mfi
neg
control
mfi
sampl
mfi
neg
control
reproduc
assay
assess
determin
level
intraassay
interassay
variat
intraassay
variat
within
plate
calcul
mean
percentag
coeffici
variat
cv
sampl
determin
triplic
interassay
variat
assess
test
panel
sampl
posit
sera
neg
sera
three
separ
run
elisa
perform
block
elisa
kit
svanova
biotech
ab
uppsala
sweden
accord
manufactur
instruct
kit
sensit
specif
compar
viru
neutral
test
svanova
biotech
ab
uppsala
sweden
receiv
oper
characterist
roc
curv
gener
assess
diagnost
perform
bmia
roc
curv
plot
test
true
posit
fraction
tpf
versu
falseposit
fraction
fpf
possibl
cutoff
valu
test
could
achiev
best
relationship
diagnost
sensit
specif
detilleux
et
al
greiner
gardner
sensit
specif
calcul
follow
formula
sensit
true
posit
true
posit
fals
neg
specif
true
neg
true
neg
fals
posit
analysi
perform
softwar
medcalc
medcalc
softwar
mariakerk
belgium
coupl
effici
mab
microspher
compar
differ
amount
mab
coupl
reaction
dilut
phycoerythrinlabel
antimous
igg
peigg
shown
fig
low
mfi
valu
g
mab
use
coupl
reaction
gml
peigg
g
gave
mfi
valu
wherea
gave
mfi
valu
indic
amount
mab
higher
coupl
effici
increas
g
g
less
effect
mfi
valu
therefor
g
select
final
captur
antibodi
coupl
microspher
use
detect
antibodi
studi
two
key
factor
bmia
determin
sandwich
immunoassay
optim
serum
dilut
factor
amount
detect
antibodi
twofold
dilut
serum
sampl
gave
maximum
differ
mfi
valu
posit
neg
sera
fig
titrat
biotinyl
detect
antibodi
show
mfi
valu
reach
plateau
gml
fig
maxim
sensit
assay
gml
use
assay
correspond
maximum
plateau
mfi
valu
sensit
specif
bmia
compar
commerci
block
elisa
total
sampl
test
parallel
two
assay
result
present
tabl
base
nonparametr
roc
analysi
sampl
cutoff
valu
percentag
inhibit
bmia
determin
cutoff
valu
bmia
classifi
sampl
posit
includ
serum
sampl
sampl
neg
tabl
compar
block
elisa
bmia
sensit
specif
fig
select
captur
antibodi
accord
coupl
effici
two
mab
indic
amount
coupl
million
microspher
reaction
volum
respect
median
floresc
intens
mfi
determin
variou
dilut
antimous
iggp
conjug
reproduc
bmia
evalu
intraand
interassay
variabl
variat
differ
prepar
conjug
microspher
mean
cv
sampl
test
triplic
one
plate
interassay
variat
determin
test
sampl
three
separ
run
mean
cv
reproduc
differ
prepar
conjug
microspher
also
investig
percentag
coeffici
variat
cv
within
three
prepar
bead
less
studi
describ
develop
evalu
microspherebas
immunoassay
rapid
sensit
detect
bovin
viral
diarrhoea
viru
antibodi
diagnost
perform
new
bmia
compar
commerci
block
elisa
system
test
larg
panel
bovin
sera
gener
two
assay
work
consist
detect
bvdv
antibodi
sampl
six
sampl
posit
bmia
neg
elisa
sampl
percentag
inhibit
valu
block
elisa
one
reason
discrep
could
sera
block
bind
viral
antigen
detect
antibodi
bmia
lead
falseposit
result
like
due
slight
higher
sensit
mia
elisa
one
sampl
neg
bmia
posit
elisa
percentag
inhibit
valu
cutoff
valu
observ
discrep
line
anoth
comparison
elisa
luminex
assay
detect
human
papillomaviru
six
sampl
react
differ
two
assay
faust
et
al
press
bmia
utilis
two
mab
highli
conserv
protein
bvdv
demonstr
assay
capabl
detect
antibodi
would
interest
detect
antibodi
avail
novel
pestivirus
khonkaen
liu
et
al
liu
et
al
propos
new
speci
liu
et
al
anoth
direct
would
extend
assay
detect
antibodi
virus
eg
bovin
herpesviru
type
bovin
respiratori
syncyti
viru
bovin
coronaviru
bovin
viru
thu
allow
robust
diagnosi
bovin
respiratori
diseas
multiplex
format
power
luminex
assay
lie
multiplex
capac
khan
et
al
report
multiplex
microbead
immunoassay
simultan
detect
antibodi
six
nonhumanprim
virus
multiplex
bring
high
cost
bmia
dramat
reduc
number
elisa
kit
pathogen
labour
input
handson
time
turn
increas
applic
assay
summari
bmia
describ
altern
elisa
detect
antibodi
bvdv
assay
reliabl
sensit
provid
power
tool
bvd
surveil
programm
addit
assay
extend
multiplex
format
allow
robust
highthroughput
diagnosi
bovin
respiratori
diseas
